Argentus Capital Management’s Merck MRK Stock Holding History

Argentus Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-6,089	Closed	-$363K	–	306
2016 Q3	$363K	Buy	6,089 +974	+19%	+$57K	0.13%	215
2016 Q2	$281K	Sell	5,115 -481	-9%	-$25.6K	0.12%	259
2016 Q1	$283K	Buy	5,596 +3,998	+250%	+$196K	0.1%	251
2015 Q4	$81K	Sell	1,598 -8,499	-84%	-$429K	0.03%	360
2015 Q3	$476K	Sell	10,097 -11,823	-54%	-$628K	0.07%	247
2015 Q2	$1.19M	Buy	+21,920	New	+$1.23M	0.18%	157

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Argentus Capital Management's MRK Position: Q4 2016 in Review

Argentus Capital Management sold out of Merck (MRK) in Q4 2016, closing a stake of 6,089 shares — an estimated $363K sold.

Argentus Capital Management first reported a position in MRK in Q2 2015 and held it in 6 quarters. The position peaked at $1.19M in Q2 2015. 1,912 funds tracked by Wall St. Rank hold MRK as of Q4 2016.

Argentus Capital Management reported no remaining Merck position as of Q4 2016 after selling out during the quarter.
Argentus Capital Management sold 6,089 Merck shares in Q4 2016, an estimated $363K.
Argentus Capital Management first reported a position in Merck in Q2 2015 and held it in 6 quarters.
Argentus Capital Management's Merck position peaked at $1.19M in Q2 2015.
1,912 funds tracked by Wall St. Rank held Merck as of Q4 2016.

Based on Argentus Capital Management's 13F filing for Q4 2016.